This study will evaluate the safety and efficacy of tucatinib in combination with trastuzumab deruxtecan.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina (Statewide)
Lisa Carey
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Breast)
21-0342
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
